Cargando…
Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
The World Health Organization declared the COVID-19 epidemic a public health emergency of international concern on March 11th, 2020, and the pandemic is rapidly spreading worldwide. COVID-19 is caused by a novel coronavirus SARS-CoV-2, which enters human target cells via angiotensin converting enzym...
Autores principales: | Barker, Harlan, Parkkila, Seppo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592753/ https://www.ncbi.nlm.nih.gov/pubmed/33112891 http://dx.doi.org/10.1371/journal.pone.0240647 |
Ejemplares similares
-
Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species
por: Zhang, Hong-Liang, et al.
Publicado: (2021) -
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
por: Oz, Murat, et al.
Publicado: (2021) -
Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
por: Oz, Murat, et al.
Publicado: (2021) -
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
por: Bian, Jingwei, et al.
Publicado: (2021) -
SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021)